Medpace Holdings Inc
NASDAQ:MEDP
Medpace Holdings Inc
NASDAQ:MEDP
Price:
447.12
USD
0.15%
Market Cap:
$12.6B
Relative Value
The Relative Value of one
MEDP
stock under the Base Case scenario is
443.07
USD.
Compared to the current market price of 447.12 USD,
Medpace Holdings Inc
is
Overvalued by 1%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MEDP
Relative Value
Base Case
443.07
USD
Overvaluation 1%
Multiples Across Competitors
MEDP Competitors Multiples
Medpace Holdings Inc Competitors
Medpace Holdings Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Medpace Holdings Inc
NASDAQ:MEDP
|
12.6B USD | 5 | 28.1 | 21.6 | 22.7 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD | 375.4 | 4 444.8 | 1 409.2 | 3 011 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
191.7B USD | 4.3 | 28.5 | 19.9 | 26.8 | |
| US |
|
Danaher Corp
NYSE:DHR
|
148.2B USD | 6 | 41 | 22.7 | 34.5 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
137.1T KRW | 14.6 | 50.2 | 50.7 | 67.5 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
36.8B CHF | 5.7 | 39.3 | 28.8 | 28.8 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
291.5B CNY | 6.6 | 19.4 | 19.7 | 19.7 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
35.3B USD | 5 | 26.5 | 19.4 | 23 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.7B USD | 1.7 | 20.4 | 11.5 | 17.2 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
28B USD | 6.9 | 32.1 | 23.7 | 26.3 | |
| CN |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
164.6B HKD | 7.3 | 34.7 | 24.4 | 24.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
